These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29432954)

  • 1. Mechanistic insights and therapeutic opportunities of antimicrobial chemokines.
    Crawford MA; Margulieux KR; Singh A; Nakamoto RK; Hughes MA
    Semin Cell Dev Biol; 2019 Apr; 88():119-128. PubMed ID: 29432954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis.
    Crawford MA; Lowe DE; Fisher DJ; Stibitz S; Plaut RD; Beaber JW; Zemansky J; Mehrad B; Glomski IJ; Strieter RM; Hughes MA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17159-64. PubMed ID: 21949405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme.
    Ragland SA; Criss AK
    PLoS Pathog; 2017 Sep; 13(9):e1006512. PubMed ID: 28934357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.
    Crawford MA; Fisher DJ; Leung LM; Lomonaco S; Lascols C; Cannatelli A; Giani T; Rossolini GM; Doi Y; Goodlett DR; Allard MW; Sharma SK; Khan E; Ernst RK; Hughes MA
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-form KLKLLLLLKLK-NH
    Manabe T; Kawasaki K
    Sci Rep; 2017 Mar; 7():43384. PubMed ID: 28262682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial agents targeting bacterial cell walls and cell membranes.
    Bush K
    Rev Sci Tech; 2012 Apr; 31(1):43-56. PubMed ID: 22849267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.
    Donovan DM
    Recent Pat Biotechnol; 2007; 1(2):113-22. PubMed ID: 19075835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Three Bacterial Lines of Defense against Antimicrobial Agents.
    Zhou G; Shi QS; Huang XM; Xie XB
    Int J Mol Sci; 2015 Sep; 16(9):21711-33. PubMed ID: 26370986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
    Nijnik A; Madera L; Ma S; Waldbrook M; Elliott MR; Easton DM; Mayer ML; Mullaly SC; Kindrachuk J; Jenssen H; Hancock RE
    J Immunol; 2010 Mar; 184(5):2539-50. PubMed ID: 20107187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.
    Yang D; Chen Q; Hoover DM; Staley P; Tucker KD; Lubkowski J; Oppenheim JJ
    J Leukoc Biol; 2003 Sep; 74(3):448-55. PubMed ID: 12949249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.
    Malanovic N; Lohner K
    Biochim Biophys Acta; 2016 May; 1858(5):936-46. PubMed ID: 26577273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
    Hale JD; Hancock RE
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.
    Batoni G; Maisetta G; Esin S
    Biochim Biophys Acta; 2016 May; 1858(5):1044-60. PubMed ID: 26525663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion to cell-penetrating peptides will enable lytic enzymes to kill intracellular bacteria.
    Borysowski J; Górski A
    Med Hypotheses; 2010 Jan; 74(1):164-6. PubMed ID: 19656633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics.
    Lohner K; Blondelle SE
    Comb Chem High Throughput Screen; 2005 May; 8(3):241-56. PubMed ID: 15892626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent development of small antimicrobial peptidomimetics.
    Niu Y; Wang RE; Wu H; Cai J
    Future Med Chem; 2012 Sep; 4(14):1853-62. PubMed ID: 23043481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents.
    Valdivia-Silva J; Medina-Tamayo J; Garcia-Zepeda EA
    Int J Mol Sci; 2015 Jun; 16(6):12958-85. PubMed ID: 26062132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides: Cell Membrane and Microbial Surface Interactions.
    Lohner K; Hilpert K
    Biochim Biophys Acta; 2016 May; 1858(5):915-7. PubMed ID: 26965988
    [No Abstract]   [Full Text] [Related]  

  • 19. Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.
    Söbirk SK; Mörgelin M; Egesten A; Bates P; Shannon O; Collin M
    PLoS One; 2013; 8(3):e58129. PubMed ID: 23533582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic antibiofilm peptides.
    de la Fuente-Núñez C; Cardoso MH; de Souza Cândido E; Franco OL; Hancock RE
    Biochim Biophys Acta; 2016 May; 1858(5):1061-9. PubMed ID: 26724202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.